The DOI matches its Crossref record; 46 of the 48 references it cites were found in a registry or an index.
Inhibition of the Differentiation of Dendritic Cells From CD34+ Progenitors by Tumor Cells: Role of Interleukin-6 and Macrophage Colony-Stimulating Factor
Abstract
The escape of malignant cells from the immune response against the tumor may result from a defective differentiation or function of professional antigen-presenting cells (APC), ie, dendritic cells (DC). To test this hypothesis, the effect of human renal cell carcinoma cell lines (RCC) on the development of DC from CD34(+) progenitors was investigated in vitro. RCC cell lines were found to release soluble factors that inhibit the differentiation of CD34(+) cells into DC and trigger their commitment towards monocytic cells (CD14(+)CD64(+)CD1a-CD86(-)CD80(-)HLA-D Rlow) with a potent phagocytic capacity but lacking APC function. RCC CM were found to act on the two distinct subpopulations emerging in the culture at day 6 ([CD14(+)CD1a-] and [CD14(-)CD1a+]) by inhibiting the differentiation into DC of [CD14(+)CD1a-] precursors and blocking the acquisition of APC function of the [CD14(-)CD1a+] derived DC. Interleukin-6 (IL-6) and macrophage colony-stimulating factor (M-CSF) were found to be responsible for this phenomenon: antibodies against IL-6 and M-CSF abrogated the inhibitory effects of RCC CM; and recombinant IL-6 and/or M-CSF inhibited the differentiation of DC similarly to RCC CM. The inhibition of DC differentiation by RCC CM was preceeded by an induction of M-CSF receptor (M-CSFR; CD115) and a loss of granulocyte-macrophage colony-stimulating factor receptor (GM-CSFR; CD116) expression at the surface of CD34(+) cells, two phenomenon reversed by anti-IL-6/IL-6R and anti-M-C…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CSF-2 in isolation also promotes their differentiation into a dendritic cell lineage, which maintains a phagocytic phenotype (CD68 immunopositive) [17, 30].”
From Loss of homeostatic microglial phenotype in CSF1R-related Leukoencephalopathy (2020) · cites this paper as [30]
Citations
Cites
The Dendritic Cell System and its Role in Immunogenicity
Steinman, R. M. (1991) · Annual Review of Immunology · doi:10.1146/annurev.iy.09.040191.001415 · Cited by 4,659
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977
Vaccination of patients with B–cell lymphoma using autologous antigen–pulsed dendritic cells
Hsu, F. J., Benike, C., Fagnoni, F., Liles, T. M., Czerwinski, D., Taidi, B., Engleman, E. G., & Levy, R. (1996) · Nature Medicine · doi:10.1038/nm0196-52 · Cited by 1,804
GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells
Caux, C., Dezutter‐Dambuyant, C., Schmitt, D., & Banchereau, J. (1992) · Nature · doi:10.1038/360258a0 · Cited by 1,551
Self-citationSchwartz, R. H. (1992) · Cell · doi:10.1016/s0092-8674(05)80055-8 · Cited by 1,293
Induction of tolerance by IL-10-treated dendritic cells
Steinbrink, K., Wölfl, M., Jonuleit, H., Knop, J., & Enk, A. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.10.4772 · Cited by 1,245
Caux, C., Vanbervliet, B., Massacrier, C., Dezutter‐Dambuyant, C., de Saint-Vis, B., Jacquet, C., Yoneda, K., Imamura, S., Schmitt, D., & Banchereau, J. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.184.2.695 · Cited by 920
Self-citationZitvogel, L., Mayordomo, J. I., Tjandrawan, T., DeLeo, A. B., Clarke, M. R., Lotze, M. T., & Storkus, W. J. (1996) · The Journal of Experimental Medicine · doi:10.1084/jem.183.1.87 · Cited by 824
Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily.
Zhou, L., & Tedder, T. F. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.8.3821 · Cited by 751
Kawasaki, E. S., Ladner, M. B., Wang, A. M., Arsdell, J. V., Warren, M. K., Coyne, M. Y., Schweickart, V. L., Lee, M.-T., Wilson, K. J., Boosman, A., et al. (1985) · Science · doi:10.1126/science.2996129 · Cited by 523
Research works printed but not linked: 1
- Négrier, 1996, The FNCLCC CRECY trial: Interleukin 2 (IL2) + interferon (IFN)-α is the optimal treatment to induce responses in metastatic renal cell carcinoma (MRCC)., Proc Am Soc Clin Oncol, 15, 248
Cited by
Sorted by citations
Items 301–400 of 590
Salter, R. D., & Shurin, M. R. (2009) · Springer eBooks · doi:10.1007/978-0-387-88611-4 · Cited by 32
Human Prostate Cancer Blocks the Generation of Dendritic Cells from CD34+ Hematopoietic Progenitors
Shurin, G. V., Aalamian, M., Pirtskhalaishvili, G., Быковская, С. Н., Huland, E., Huland, H., & Shurin, M. R. (2001) · European Urology · doi:10.1159/000052584 · Cited by 31
Data Driven Mathematical Model of Colon Cancer Progression
Kirshtein, A., Akbarinejad, S., Hao, W., Le, T., Su, S., Aronow, R. A., & Shahriyari, L. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123947 · Cited by 29
Encabo, A., Solves, P., Mateu, E., Sepúlveda, P., Carbonell‐Uberos, F., & Miñana, M. D. (2004) · Stem Cells · doi:10.1634/stemcells.22-5-725 · Cited by 30
Porta, M. G. D., Rigolin, G. M., Alessandrino, E. P., Maiocchi, M., Malcovati, L., Vanelli, L., Baratè, C., Rumi, E., Ciccone, M., Cuneo, A., et al. (2003) · European Journal Of Haematology · doi:10.1046/j.0902-4441.2004.00172.x · Cited by 30
New Perspectives in Glioma Immunotherapy
Daga, A., Bottino, C., Castriconi, R., Gangemi, R. M. R., & Ferrini, S. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211797249206 · Cited by 31
Corvalán, L., Araya, R., Brañes, M. C., Sáez, P. J., Kalergis, A. M., Tobar, J. A., Theis, M., Willecke, K., & Sáez, J. C. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20971 · Cited by 30
Cross-Talk Between Mesenchymal Stem/Stromal Cells and Dendritic Cells
Đokić, J., Tomić, S., & Čolić, M. J. (2016) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x10666150904114035 · Cited by 30
Milano, F., Jorritsma, T., Rygiel, A. M., Bergman, J. J. G. H. M., Sondermeijer, C., ten Brinke, A., vanHam, S. M., & Krishnadath, K. K. (2008) · Scandinavian Journal of Immunology · doi:10.1111/j.1365-3083.2008.02183.x · Cited by 30
Immunoevolution of mouse pancreatic organoid isografts from preinvasive to metastatic disease
Filippini, D., D’Agosto, S. L., Delfino, P., Simbolo, M., Piro, G., Rusev, B. C., Veghini, L., Cantù, C., Lupo, F., Ugel, S., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-48663-7 · Cited by 30
Dendritic Cells for Specific Cancer Immunotherapy
Meidenbauer, N., Andreesen, R., & Mackensen, A. (2001) · Biological Chemistry · doi:10.1515/bc.2001.065 · Cited by 28
Curti, A., Pandolfi, S., Aluigi, M., Isidori, A., Alessandrini, I., Chiodoni, C., Testoni, N., Colombo, M. P., Baccarani, M., & Lemoli, R. M. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2005.08.005 · Cited by 29
Patient-tailored modulation of the immune system may revolutionize future lung cancer treatment
Heuvers, M. E., Aerts, J. G. J. V., Cornelissen, R., Groen, H. J. M., Hoogsteden, H. C., & Hegmans, J. P. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-580 · Cited by 28
Monocytes and Macrophages in Cancer: Unsuspected Roles
Gouveia-Fernandes, S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-34025-4_9 · Cited by 28
Molecular Mechanisms of Kaposi Sarcoma Development
Karabajakian, A., Ray-Coquard, I. L., & Blay, J. (2022) · Cancers · doi:10.3390/cancers14081869 · Cited by 28
Self-citationGousias, K., von Ruecker, A., Voulgari, P. V., & Simon, M. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.09.001 · Cited by 28
van Cruijsen, H., Hoekman, K., Stam, A. G. M., van den Eertwegh, A. J. M., Kuenen, B. C., Scheper, R. J., Giaccone, G., & de Gruijl, T. D. (2007) · Clinical and Developmental Immunology · doi:10.1155/2007/17315 · Cited by 28
Ávila‐Moreno, F., López-González, J. S., Galindo-Rodrı́guez, G., Prado-Garcı́a, H., Bajaña, S., & Sánchez‐Torres, C. (2005) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-005-0060-3 · Cited by 28
Interplay Between Human Papillomaviruses and Dendritic Cells
Offringa, R., de Jong, A., Toes, R. E. M., van der Burg, S. H., & Melief, C. J. M. (2003) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-06508-2_10 · Cited by 28
Cross-Talk between Tumor and Myeloid Cells: How to Tip the Balance in Favor of Antitumor Immunity
Lindenberg, J. J., Fehres, C. M., van Cruijsen, H., Oosterhoff, D., & de Gruijl, T. D. (2010) · Immunotherapy · doi:10.2217/imt.10.95 · Cited by 27
Dendritic Cells: The Long and Evolving Road towards Successful Targetability in Cancer
Marmonti, E., Oliva, J., & Haymaker, C. (2022) · Cells · doi:10.3390/cells11193028 · Cited by 29
Farren, M. R., Carlson, L. M., & Lee, K. P. (2009) · Immunologic Research · doi:10.1007/s12026-009-8118-5 · Cited by 27
Kim, H. S., Kim, J. Y., Ryu, H. S., Shin, B. R., Kang, J. S., Kim, H. M., Kim, Y. O., Hong, J. T., Kim, Y. S., & Han, S. (2011) · Journal of Medicinal Food · doi:10.1089/jmf.2011.1575 · Cited by 27
Appel, S., Bringmann, A., Grünebach, F., Weck, M., Bauer, J., & Brossart, P. (2006) · Blood · doi:10.1182/blood-2005-06-2480 · Cited by 28
Rapp, M., Özcan, Z., Steiger, H., Wernet, P., Sabel, M., & Sorg, R. V. (2006) · Journal of neurosurgery · doi:10.3171/jns.2006.105.1.41 · Cited by 27
Friedl, J., Stift, A., Paolini, P., Roth, E., Steger, G. G., Mader, R. M., Jakesz, R., & Gnant, M. (2000) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/cbr.2000.15.477 · Cited by 27
VEGF IN NEOPLASTIC ANGIOGENESIS
Chekhonin, V. P., Shein, S. A., Korchagina, A. A., & Gurina, O. I. (2012) · Annals of the Russian academy of medical sciences · doi:10.15690/vramn.v67i2.119 · Cited by 26
Data Driven Mathematical Model of FOLFIRI Treatment for Colon Cancer
Budithi, A., Su, S., Kirshtein, A., & Shahriyari, L. (2021) · Cancers · doi:10.3390/cancers13112632 · Cited by 25
Dendritic Cell Activation by Glucan Isolated fromUmbilicaria Esculenta
Kim, H. S., Kim, J. Y., Lee, H. K., Kim, M. S., Lee, S. R., Kang, J. S., Kim, H. M., Lee, K., Hong, J. T., Kim, Y., et al. (2010) · Immune Network · doi:10.4110/in.2010.10.6.188 · Cited by 26
Bruchard, M., & Ghiringhelli, F. (2014) · médecine/sciences · doi:10.1051/medsci/20143004018 · Cited by 29
Osali, A., Zhiani, M., Ghaebi, M., Meymanat, M., & Esmaeilzadeh, A. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105094 · Cited by 25
Micheva, I., Marinakis, T., Repa, C., Kouraklis‐Symeonidis, A., Vlacha, V., Anagnostopoulos, N. I., Zoumbos, N. C., & Symeonidis, A. S. (2006) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2005.12.029 · Cited by 25
A generic RNA-pulsed dendritic cell vaccine strategy for renal cell carcinoma
Geiger, C., Regn, S., Weinzierl, A. O., Noeßner, E., & Schendel, D. J. (2005) · Journal of Translational Medicine · doi:10.1186/1479-5876-3-29 · Cited by 25
Alberti, L., Bachelot, T., Duc, A., Biota, C., & Blay, J. (2005) · Cancer Research · doi:10.1158/0008-5472.2.65.1 · Cited by 25
Self-citationZhao, L., Shao, Q., Zhang, Y., Zhang, L., He, Y., Wang, L., Kong, B., & Qu, X. (2016) · Scientific Reports · doi:10.1038/srep20409 · Cited by 25
Yamamoto, M., Saito, H., Uejima, C., Tanio, A., Takaya, S., Sakamoto, T., Honjo, S., Maeta, Y., Ashida, K., & Fujiwara, Y. (2018) · Surgery Today · doi:10.1007/s00595-018-1689-9 · Cited by 25
Haruki, K., Shiba, H., Fujiwara, Y., Furukawa, K., Wakiyama, S., Ogawa, M., Ishida, Y. Y., Misawa, T., & Yanaga, K. K. (2013) · PubMed · Cited by 25
Wnt5a Inhibits Human Monocyte‐Derived Myeloid Dendritic Cell Generation
Bergenfelz, C., Janols, H., Wullt, M., Jirström, K., Bredberg, A. C. A., & Leandersson, K. (2013) · Scandinavian Journal of Immunology · doi:10.1111/sji.12075 · Cited by 25
Molecular and Cellular Mechanisms of Antitumor Immune Response Activation by Dendritic Cells
Markov, O. V., Mironova, N. L., Vlassov, V. V., & Аркадьевна, З. М. (2016) · Acta Naturae · doi:10.32607/20758251-2016-8-3-17-30 · Cited by 25
Dendritic cells in autoimmune disorders and cancer of the thyroid
Lewiñski, A., Śliwka, P. W., & Stasiołek, M. (2014) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.2014.0002 · Cited by 24
Immunotherapeutic strategies employing RNA interference technology for the control of cancers
Mao, C.-P., Hung, C., & Wu, T. ‐. (2006) · Journal of Biomedical Science · doi:10.1007/s11373-006-9131-5 · Cited by 24
Dendritic cell‐based cancer immunotherapy: Potential for treatment of colorectal cancer?
Chen, W., Rains, N., Young, D. A., & Stubbs, R. S. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02241.x · Cited by 24
The ‘Danse Macabre’—Neutrophils the Interactive Partner Affecting Oral Cancer Outcomes
Hadjigol, S., Shah, B. A., & O’brien-simpson, N. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.894021 · Cited by 26
Hoshino, Y., Takagi, S., Osaki, T., Okumura, M., & FUJINAGA, T. (2008) · Journal of Veterinary Medical Science · doi:10.1292/jvms.70.581 · Cited by 23
Tumor Induced Hepatic Myeloid Derived Suppressor Cells Can Cause Moderate Liver Damage
Eggert, T., Medina‐Echeverz, J., Kapanadze, T. G., Kruhlak, M. J., Korangy, F., & Greten, T. F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112717 · Cited by 23
Sittig, S. P., de Vries, I. J. M., & Schreibelt, G. (2015) · Biomedicines · doi:10.3390/biomedicines3040282 · Cited by 23
Toma, M. I., Wehner, R., Kloß, A., Hübner, L., Fodelianaki, G., Erdmann, K., Fuessel, S., Zastrow, S., Meinhardt, M., Seliger, B., et al. (2015) · OncoImmunology · doi:10.1080/2162402x.2015.1008342 · Cited by 23
Dendritic cells: therapy and imaging
Pham, W. N., Kobukai, S., Hotta, C., & Gore, J. C. (2009) · Expert Opinion on Biological Therapy · doi:10.1517/14712590902867739 · Cited by 20
Young, M. R. I., Wright, M. A., Vellody, K., & Lathers, D. M. R. (1999) · International Journal of Immunopharmacology · doi:10.1016/s0192-0561(99)00044-2 · Cited by 22
Nagai, H., & Sumino, Y. (2008) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/157489208786242296 · Cited by 22
Memeo, R., Blasi, V. D., Adam, R. A., Goèré, D., Laurent, A., de’Angelis, N., Piardi, T., Lermite, É., Herrero, A., Navarro, F., et al. (2018) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-018-3854-2 · Cited by 22
Baron, C. L., Raposo, G., Scholl, S., Bausinger, H., Tenza, D., Bohbot, A., Pouillart, P., Goud, B., Hanau, D., & Salamero, J. (2001) · Journal of Cell Science · doi:10.1242/jcs.114.5.999 · Cited by 22
Vitamin D3 and analogues modulate the expression of CSF-1 and its receptor in human dendritic cells
Zhu, K., Gläser, R., & Mrowietz, U. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02357-4 · Cited by 22
Berthier‐Vergnes, O., Gaucherand, M., Navarro, J., Plouët, J., Pageaux, J.-F., Schmitt, D., & Mj, S. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2183 · Cited by 22
Mollah, Z. U. A., Aiba, S., Nakagawa, S., Hara, M., Manome, H., Mizuashi, M., Ohtani, T., Yoshino, Y., & Tagami, H. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12036.x · Cited by 22
Mashino, K., Sadanaga, N., Tanaka, F., Ohta, M., Yamaguchi, H., & Mori, M. (2002) · PubMed · Cited by 22
Modulation of T cell function and survival by the tumor microenvironment
Mani, N. L., Andrews, D., & Obeng, R. C. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1191774 · Cited by 22
Famta, P., Shah, S., Vambhurkar, G., Pandey, G., Bagasariya, D., Kumar, K. C., Prasad, S. B., Shinde, A., Wagh, S., Srinivasarao, D. A., et al. (2025) · Drug Delivery and Translational Research · doi:10.1007/s13346-024-01669-9 · Cited by 21
Leontovich, A. A., Dronca, R. S., Nevala, W. K., Thompson, M. A., Kottschade, L. A., Ivanov, L. V., & Markovic, S. N. (2016) · Melanoma Research · doi:10.1097/cmr.0000000000000290 · Cited by 20
Perdijk, O., van Neerven, R. J. J., van den Brink, E., Savelkoul, H. F. J., & Brugman, S. (2018) · PLoS ONE · doi:10.1371/journal.pone.0200356 · Cited by 21
Inhibition of the Differentiation of Monocyte-Derived Dendritic Cells by Human Gingival Fibroblasts
Séguier, S., Tartour, É., Guérin, C. L., Couty, L., Lemitre, M., Lallement, L., Folliguet, M., Naderi, S., Terme, M., Badoual, C., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070937 · Cited by 21
Slager, E. H., van der Minne, C. E., Krüse, M., Krueger‐Burg, D., Griffioen, M., & Osanto, S. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.5095 · Cited by 21
Characterization of Monocyte-Derived Dendritic Cells in Recent-Onset Diabetes Mellitus Type 1
Zacher, T., Knerr, I., Rascher, W., Kalden, J. R., & Waßmuth, R. (2002) · Clinical Immunology · doi:10.1006/clim.2002.5265 · Cited by 21
Ghorbaninezhad, F., Nour, M. A., Farzam, O. R., Saeedi, H., Vanan, A. G., Bakhshivand, M., Jafarlou, M., Hatami‐Sadr, A., & Baradaran, B. (2025) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2025.189281 · Cited by 26
Mollah, Z. U. A., Aiba, S., Manome, H., Yoshino, Y., & Tagami, H. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01692.x · Cited by 20
Saunders, R. M., Kaur, D., Desai, D., Berair, R., Chachi, L., Thompson, R. D., Siddiqui, S., & Brightling, C. E. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1205 · Cited by 19
Zhang, R., Meifen, X., Ji, X., Gu, L., Yang, X., Wang, H., & Jiang, P. (2010) · Cytokine · doi:10.1016/j.cyto.2010.02.017 · Cited by 19
Hong, C., Lee, C., Chen, G., Chang, K., & Yu, H. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2014.12.030 · Cited by 19
Zhaoa, I.-M., Xua, H.-J., Kanga, X., Zhaoa, A.-M., & Luc, L.-M. (2016) · Cited by 19
Baskić, D., Vujanovic, L. N., Arsenijević, N., Whiteside, T. L., Myers, E. N., & Vujanović, N. L. (2012) · Head & Neck · doi:10.1002/hed.22968 · Cited by 19
Fujii, S., Shimizu, K., Koji, F., & Kawano, F. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0602267 · Cited by 19
Mechanisms of Immune Dysfunction in Renal Cell Carcinoma
Derweesh, I., Tannenbaum, C. S., Rayman, P. A., & Finke, J. H. (2003) · Cancer treatment and research · doi:10.1007/978-1-4615-0451-1_2 · Cited by 19
Seliger, B., & Massa, C. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00419 · Cited by 19
Tumor-Induced Immune Suppression
Gabrilovich, D. I., & Hurwitz, A. A. (2007) · Springer eBooks · doi:10.1007/978-0-387-69118-3 · Cited by 18
Lo, A. S., Gorak‐Stolinska, P., Bachy, V. S., Ibrahim, M. A. A., Kemeny, D. M., & Maher, J. F. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0307142 · Cited by 18
Wu, X., Gao, H., Bleday, R., & Zhu, Z. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.509158 · Cited by 18
A GM-CSF/CD40L Producing Cell Augments Anti-tumor T Cell Responses
Dessureault, S., Alsarraj, M., McCarthy, S. M., Hunter, T. B., Noyes, D. R., Lee, D., Harkins, J., Seigne, J. D., Jennings, R., & Antonia, S. J. (2005) · Journal of Surgical Research · doi:10.1016/j.jss.2004.11.036 · Cited by 18
Pinzón‐Charry, A., Maxwell, T., Prato, S., Furnival, C. M., Schmidt, C., & López, J. A. (2005) · Neoplasia · doi:10.1593/neo.05448 · Cited by 18
Fujimoto, N., Akagi, A., & Tajima, S. (2004) · Experimental Dermatology · doi:10.1111/j.0906-6705.2004.0154.x · Cited by 17
The Role of Myeloid-Derived Suppressor Cells in Tumor Growth and Metastasis
Bayık, D., Lee, J., & Lathia, J. D. (2022) · Experientia supplementum · doi:10.1007/978-3-030-91311-3_7 · Cited by 17
Gersuk, G. M., Hiraoka, A., & Marr, K. A. (2005) · Journal of Immunological Methods · doi:10.1016/j.jim.2005.01.018 · Cited by 17
Tumor-Associated Macrophages as a Source of Functional Dendritic Cells in Ovarian Cancer Patients
Chu, C., Woo, E. Y., Toll, A. J., Rubin, S. C., June, C. H., Carroll, R. G., & Schlienger, K. (2002) · Clinical Immunology · doi:10.1006/clim.2001.5179 · Cited by 17
Strobl, H. (2003) · International Archives of Allergy and Immunology · doi:10.1159/000070921 · Cited by 17
Clinical update: Novel targets in multiple myeloma
Anderson, K. C. (2004) · Seminars in Oncology · doi:10.1053/j.seminoncol.2004.10.016 · Cited by 17
Curti, A., Tafuri, A., Ricciardi, M. R., Tazzari, P. L., Petrucci, M. T., Fogli, M., Ratta, M., Lapalombella, R., Ferri, E., Tura, S., et al. (2002) · PubMed · Cited by 17
Harada, K., Ihara, F., Takami, M., Kamata, T., Mise, N., Yoshizawa, H., Hishiki, T., Saito, T., Terui, K., Nakata, M., et al. (2019) · Cancer Science · doi:10.1111/cas.13933 · Cited by 16
Borràs, F. E., Matthews, N., Patel, R., & Navarrete, C. (2000) · Bone Marrow Transplantation · doi:10.1038/sj.bmt.1702525 · Cited by 16
Increased pressure stimulates aberrant dendritic cell maturation
Craig, D., Schaubert, K. L., Shiratsuchi, H., Kan‐Mitchell, J., & Basson, M. D. (2007) · Cellular & Molecular Biology Letters · doi:10.2478/s11658-007-0054-6 · Cited by 16
Margonis, G. A., Amini, N., Kim, Y., Tran, T. B., Postlewait, L. M., Maithel, S. K., Wang, T. S., Evans, D. B., Hatzaras, I. S., Shenoy, R. S., et al. (2015) · World Journal of Surgery · doi:10.1007/s00268-015-3307-y · Cited by 17
Khatib, S. A., Rossi, E. L., Bowers, L. W., & Hursting, S. D. (2016) · Prostaglandins & Other Lipid Mediators · doi:10.1016/j.prostaglandins.2016.07.011 · Cited by 16
Li, R., Leng, A., Liu, T., Zhou, Y., Zeng, J.-X., Liu, X., Hu, T., Jiang, X., Zhang, L., & Xu, C. (2017) · BioMed Research International · doi:10.1155/2017/5090534 · Cited by 16
Marta, G. N., Velho, P. I., Bonadio, R. R. C. C., Nardo, M., Faraj, S. F., Souza, M. C. L. D. A., Muniz, D. Q. B., Bastos, D. A., & Dzik, C. (2020) · Pathology & Oncology Research · doi:10.1007/s12253-020-00840-0 · Cited by 16
DC in multiple myeloma immunotherapy
Turtle, C. J., Brown, R. D., Joshua, D. E., & Hart, D. N. J. (2004) · Cytotherapy · doi:10.1080/14653240410005357 · Cited by 16
Higham, E. M., Wittrup, K. D., & Chen, J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903111 · Cited by 16
Using Signaling Pathways to Overcome Immune Tolerance to Tumors
Engleman, E. G., Brody, J., & Soares, L. R. B. (2004) · Science s STKE · doi:10.1126/stke.2412004pe28 · Cited by 16
Liu, H., Zou, M., Li, P., Wang, H., Lin, X.-J., & Ye, J. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10064 · Cited by 15
RetractedYang, N., Tan, R. P., Chan, A., Lee, B. S. L., Santos, M., Hung, J., Liao, Y. J., Bilek, M., Fei, J., Wise, S. G., et al. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01887 · Cited by 15
Wen, J., Xuan, B., Gao, Y., Liu, Y., Wang, L., He, L., Xiangcai, M., Zhou, T., Tao, Y., Guo, K., et al. (2023) · Cellular Immunology · doi:10.1016/j.cellimm.2023.104676 · Cited by 15
Guan, Y., Yu, S., Zhao, Z., Ćirić, B., Zhang, G., & Rostami, A. M. (2007) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2007.09.021 · Cited by 15
Rovida, E., & Sbarba, P. D. (2015) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000379 · Cited by 16
Metadata
- Authors
- Menetrier-Caux, C., Montmain, G., Dieu, M. C., Bain, C., Favrot, M. C., Caux, C., & Blay, J. Y.
- Affiliations
- From Unité Cytokine et Cancer, Unité INSERM 453, Centre Léon Bérard, Lyon, France; and Schering Plough, Dardilly, France.
- Inserm (FR)
- ORCID
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 1998-12-15
- Volume
- 92
- Issue
- 12
- Pages
- 4778-4791
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W193748226
- Cited by
- 590
- References
- 48
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 10 · 2023: 10 · 2022: 8 · 2021: 9 · 2020: 20 · 2019: 16 · 2018: 13 · 2017: 9 · 2016: 25 · 2015: 26 · 2014: 19 · 2013: 30 · 2012: 25
- FWCI
- 6.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Blood (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- dendritic cell differentiation, CD34+ progenitors, renal cell carcinoma, tumor immune evasion, interleukin-6, macrophage colony-stimulating factor, M-CSF receptor, GM-CSF receptor, antigen-presenting cells, monocyte differentiation, CD1a, CD14, soluble factors
- MeSH terms
- Antibodies, Carcinoma, Renal Cell, Cell Differentiation, Cell Division, Dendritic Cells, Dose-Response Relationship, Drug, Gene Expression Regulation, Humans, Lymphokines, Tumor Cells, Cultured, Interleukin-6, Immunophenotyping, Macrophage Colony-Stimulating Factor, Receptor, Macrophage Colony-Stimulating Factor, Receptors, Granulocyte-Macrophage Colony-Stimulating Factor, Endothelial Growth Factors, Culture Media, Conditioned, Antigens, CD34, Vascular Endothelial Growth Factors, Vascular Endothelial Growth Factor A, Cell Size
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review